Remedent, Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2019
February 15, 2020 at 04:11 am IST
Share
Remedent, Inc. announced earnings results for the third quarter ended December 31, 2019. For the third quarter, the company announced sales was USD 262,077 compared to USD 419,326 a year ago. Operating loss was USD 123,016 compared to USD 222,377 a year ago. Net loss was USD 148,526 compared to USD 187,753 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago. For the nine months, sales was USD 814,111 compared to USD 1.199 million a year ago. Operating loss was USD 286,714 compared to USD 491,607 a year ago. Net loss was USD 499,262 compared to USD 422,669 a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.02 a year ago.
Remedent, Inc. specializes in the research, development and manufacturing of oral care and cosmetic dentistry products. The Company designs, develops, manufactures and distributes its cosmetic dentistry products, including a full line of professional dental products that are distributed in Europe, Asia, Middle East and the United States. The Company's operating segment consists of dental products and oral hygiene products sold by Remedent Inc., Remedent N.V., and Biotech Dental Benelux N.V. The Company offers over-the-counter (OTC) tooth whitening products. It has three primary products: River 8, a prefabricated veneer; its custom-made GlamSmile Veneers and the SmileMe mirror. The Company has developed a range of prefabricated, ready-to-use veneers that the Company has branded as River8. The Company's product in the professional oral care and cosmetic dentistry is the GlamSmile veneer. The SmileMe Mirror enables the dentist to offer patients a complete Smile Consultation.
REMEDENT, INC. 